- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02503241
Open Lung Strategy in Critically Ill Morbid Obese Patients
Open Lung Strategy in Critically Ill Morbid Obese Patients Lung Imaging and Heart-lung Interaction
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Obese patients under mechanical ventilation are more likely to develop atelectasis as a consequence of the increased abdominal weight. Atelectasis is the primary responsible for respiratory insufficiency and impossibility to wean obese patients from respiratory support.
In a previous study we demonstrated the efficacy of the application of titrated PEEP levels following a recruitment maneuver in obese patients, i.e. improvement in respiratory mechanics and gas exchanges without negative hemodynamic effects.
The application of lung and heat imaging will allow us to quantitatively describe:
- Increase in aerated lung tissue (reduction of atelectasis)
- Reduction of over-inflation of the ventilated regions
- Recoupling of ventilation and perfusion
- Improvement in right heart function by reduction of right heart afterload
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ICU admitted requiring intubation and mechanical ventilation
- BMI ≥ 35 kg/m2
- Waist circumference > 88 cm (for women)
- Waist circumference > 102 cm (for men)
Exclusion Criteria:
- Known presence of esophageal varices
- Recent esophageal trauma or surgery
- Severe thrombocytopenia (Platelets count ≤ 5,000/mm3)
- Severe coagulopathy (INR ≥ 4)
- Presence or history of pneumothorax
- Pregnancy
- Patients with poor oxygenation index (PaO2/FiO2< 100 mmHg with at least 10 cmH2O of PEEP)
- Pacemaker and/or internal cardiac defibrillator
- Hemodynamic parameters: systolic blood pressure (SBP) <100 mmHg and >180 mmHg, or if SBP is between 100-180 mmHg on high dose of IV continuous infusion norepinephrine (>20 μg per minute), or dobutamine (>10 μg per minute), or dopamine (>10 μg per Kg per minute), or epinephrine (>10 μg per minute).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PEEP_Titration_INCREMENTAL
The investigators will compare 3 levels of PEEP (BASELINE versus PEEP INCREMENTAL versus PEEP DECREMENTAL). Baseline PEEP is based in the standard of care PEEP used in the participant units. PEEP incremental value is based in transpulmonary pressure. Intervention : PEEP INCREMENTAL |
PEEP was progressively increased by steps of 2 cmH2O every 60 second until the end-expiratory transpulmonary pressure became positive between 0-2 cmH2O.
Other Names:
Lung recruitment maneuver (LRM) is a transitory and controlled increase in airway pressure to open collapsed alveoli.
LRM is the first step of the PEEP DECREMENTAL method.
After LRM, PEEP is systematically decreased, in small decrements, until the best respiratory system mechanics is identified.
Other Names:
|
|
Experimental: PEEP_Titration_DECREMENTAL
The investigators will compare 3 levels of PEEP (BASELINE versus PEEP INCREMENTAL versus PEEP DECREMENTAL). Baseline PEEP is based in the standard of care PEEP used in the participant units. PEEP decremental value is based in lung recruitment maneuver followed by a best compliance curve during PEEP decrements. Intervention :PEEP DECREMENTAL |
PEEP was progressively increased by steps of 2 cmH2O every 60 second until the end-expiratory transpulmonary pressure became positive between 0-2 cmH2O.
Other Names:
Lung recruitment maneuver (LRM) is a transitory and controlled increase in airway pressure to open collapsed alveoli.
LRM is the first step of the PEEP DECREMENTAL method.
After LRM, PEEP is systematically decreased, in small decrements, until the best respiratory system mechanics is identified.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Respiratory System Elastance
Time Frame: During study time points :baseline, PEEP incremental, PEEP decremental
|
Difference in Respiratory System Elastance measured in cmH2O/L
|
During study time points :baseline, PEEP incremental, PEEP decremental
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Lung mechanics - Compliance
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental
|
Difference in respiratory system, lung and chest wall compliance measured in mL/cmH2O
|
Study time points: baseline, PEEP incremental, PEEP decremental
|
|
Lung mechanics - Airway resistances
Time Frame: During study time points: baseline, PEEP incremental, PEEP decremental
|
Difference in resistances of the airways measured as cmH2O/L/sec (Raw)
|
During study time points: baseline, PEEP incremental, PEEP decremental
|
|
Survival
Time Frame: 28 days after the performance of the study protocol
|
Incidence of death among the study population
|
28 days after the performance of the study protocol
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intra-abdominal pressure
Time Frame: Study time point: baseline
|
Changes in bladder pressure measured in mmHg.
|
Study time point: baseline
|
|
Electrical Impedance Tomography measurement: collapsed and overdistension
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental
|
Percentage of lung tissue collapsed and over distended at different PEEP levels by analyzing pixel compliance ( variation in impedance divided by applied pressure during a respiratory cycle).
|
Study time points: baseline, PEEP incremental, PEEP decremental
|
|
Electrical Impedance Tomography measurement: distribution of ventilation
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental
|
Difference in end-expiratory lung impedance as percentage estimating the distribution of ventilation among 4 horizontal regions of interest ( from non-dependent to dependent lung regions).
|
Study time points: baseline, PEEP incremental, PEEP decremental
|
|
Electrical Impedance Tomography measurement: lung perfusion
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental
|
Differences in distribution in lung perfusion measured as regional percentage of the total cardiac output.
|
Study time points: baseline, PEEP incremental, PEEP decremental
|
|
Central venous pressure
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Changes in central venous pressure (CVP, mmHg)
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Gas Exchange - Oxygenation
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Difference in oxygenation measured in mmHg of PaO2/FiO2
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Gas Exchange - Arterial carbon dioxide
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Difference in arterial carbon dioxide measured in mmHg (PaCO2)
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Lung volumes - respiratory dead space
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental.
|
Difference in dead space fraction measured as the ratio of death volume over the total tidal volume (Vd/Vt)
|
Study time points: baseline, PEEP incremental, PEEP decremental.
|
|
Heart rate
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Changes in heart rate (HR, bpm)
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Blood pressure
Time Frame: A) 48 and 24h before study procedures B)Study time points: baseline, PEEP incremental, PEEP decremental C)Follow up: 1, 2 , 24, 48 and 72 hours after study procedures.
|
Changes in invasive arterial blood pressures (BP, mmHg)
|
A) 48 and 24h before study procedures B)Study time points: baseline, PEEP incremental, PEEP decremental C)Follow up: 1, 2 , 24, 48 and 72 hours after study procedures.
|
|
Right heart function -Tricuspid Annular Plane Systolic Excursion (TAPSE)
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Differences in TAPSE measured through two-dimensional transthoracic echocardiography (apical four-chamber view).
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Right heart function - S'
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
Differences in the systolic excursion of the tricuspid annulus measured by tissue doppler imaging.
|
Study time points: baseline, PEEP incremental, PEEP decremental. Follow up: 1, 2 , 24 and 48 hours after study procedures
|
|
Right heart function - Tei index
Time Frame: Study time points: baseline, PEEP incremental, PEEP decremental
|
Differences in global right ventricular function obtained from right ventricle tissue doppler imaging.
|
Study time points: baseline, PEEP incremental, PEEP decremental
|
|
Vasopressor requirement
Time Frame: 48, 24h before AND 24, 48 and 72h after study procedures.
|
Norepinephrine (mcg/kg/min), epinephrine (mcg/kg/min) , phenylephrine ( mcg/kg/min) and vasopressin (U / min)
|
48, 24h before AND 24, 48 and 72h after study procedures.
|
|
Creatinine
Time Frame: 48, 24h before AND 24, 48 and 72h after study procedures.
|
Serum level of creatinine
|
48, 24h before AND 24, 48 and 72h after study procedures.
|
|
Urinary output
Time Frame: 48, 24h before AND 24, 48 and 72h after study procedures.
|
Changes in urinary output (mL)
|
48, 24h before AND 24, 48 and 72h after study procedures.
|
|
Fluid balance
Time Frame: 48, 24h before AND 24, 48 and 72h after study procedures.
|
Changes in fluid balance (mL)
|
48, 24h before AND 24, 48 and 72h after study procedures.
|
|
Incidence of tracheostomy
Time Frame: 28 days after the performance of the study protocol
|
Necessity of tracheostomy for prolonged ventilatory support among the study population
|
28 days after the performance of the study protocol
|
|
Duration of mechanical ventilation
Time Frame: 28 days after the performance of the study protocol
|
Number of days on mechanical ventilation
|
28 days after the performance of the study protocol
|
|
Intensive care unit length of stay
Time Frame: 28 days after the performance of the study protocol
|
Numbers of days spent in the intensive care
|
28 days after the performance of the study protocol
|
|
Hospital length of stay
Time Frame: 28 days after the performance of the study protocol
|
Numbers of days spent in the hospital
|
28 days after the performance of the study protocol
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Costa EL, Lima RG, Amato MB. Electrical impedance tomography. Curr Opin Crit Care. 2009 Feb;15(1):18-24. doi: 10.1097/mcc.0b013e3283220e8c.
- Victorino JA, Borges JB, Okamoto VN, Matos GF, Tucci MR, Caramez MP, Tanaka H, Sipmann FS, Santos DC, Barbas CS, Carvalho CR, Amato MB. Imbalances in regional lung ventilation: a validation study on electrical impedance tomography. Am J Respir Crit Care Med. 2004 Apr 1;169(7):791-800. doi: 10.1164/rccm.200301-133OC. Epub 2003 Dec 23.
- Akoumianaki E, Maggiore SM, Valenza F, Bellani G, Jubran A, Loring SH, Pelosi P, Talmor D, Grasso S, Chiumello D, Guerin C, Patroniti N, Ranieri VM, Gattinoni L, Nava S, Terragni PP, Pesenti A, Tobin M, Mancebo J, Brochard L; PLUG Working Group (Acute Respiratory Failure Section of the European Society of Intensive Care Medicine). The application of esophageal pressure measurement in patients with respiratory failure. Am J Respir Crit Care Med. 2014 Mar 1;189(5):520-31. doi: 10.1164/rccm.201312-2193CI.
- Reinius H, Jonsson L, Gustafsson S, Sundbom M, Duvernoy O, Pelosi P, Hedenstierna G, Freden F. Prevention of atelectasis in morbidly obese patients during general anesthesia and paralysis: a computerized tomography study. Anesthesiology. 2009 Nov;111(5):979-87. doi: 10.1097/ALN.0b013e3181b87edb.
- Behazin N, Jones SB, Cohen RI, Loring SH. Respiratory restriction and elevated pleural and esophageal pressures in morbid obesity. J Appl Physiol (1985). 2010 Jan;108(1):212-8. doi: 10.1152/japplphysiol.91356.2008. Epub 2009 Nov 12.
- Borges JB, Suarez-Sipmann F, Bohm SH, Tusman G, Melo A, Maripuu E, Sandstrom M, Park M, Costa EL, Hedenstierna G, Amato M. Regional lung perfusion estimated by electrical impedance tomography in a piglet model of lung collapse. J Appl Physiol (1985). 2012 Jan;112(1):225-36. doi: 10.1152/japplphysiol.01090.2010. Epub 2011 Sep 29.
- Krishnan S, Schmidt GA. Acute right ventricular dysfunction: real-time management with echocardiography. Chest. 2015 Mar;147(3):835-846. doi: 10.1378/chest.14-1335.
- Vieillard-Baron A, Jardin F. Why protect the right ventricle in patients with acute respiratory distress syndrome? Curr Opin Crit Care. 2003 Feb;9(1):15-21. doi: 10.1097/00075198-200302000-00004.
- De Santis Santiago R, Teggia Droghi M, Fumagalli J, Marrazzo F, Florio G, Grassi LG, Gomes S, Morais CCA, Ramos OPS, Bottiroli M, Pinciroli R, Imber DA, Bagchi A, Shelton K, Sonny A, Bittner EA, Amato MBP, Kacmarek RM, Berra L; Lung Rescue Team Investigators. High Pleural Pressure Prevents Alveolar Overdistension and Hemodynamic Collapse in Acute Respiratory Distress Syndrome with Class III Obesity. A Clinical Trial. Am J Respir Crit Care Med. 2021 Mar 1;203(5):575-584. doi: 10.1164/rccm.201909-1687OC.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PRICESEOBESE
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on PEEP INCREMENTAL
-
Beni-Suef UniversityNot yet recruiting
-
Ankara City Hospital BilkentNot yet recruitingMechanical Ventilation | Postoperative Pulmonary Complications | Impaired Oxygenation
-
Università degli Studi di FerraraCompletedMechanical Ventilation ComplicationItaly
-
Centre Hospitalier Intercommunal Aix-PertuisUnknownAcute Respiratory Distress SyndromeFrance
-
The First Affiliated Hospital of Xinxiang Medical...RecruitingTotal Laparoscopic Hysterectomy | Atelectasis, PostoperativeChina
-
Technical University of MadridCompleted
-
Centre Hospitalier Universitaire de BesançonUnknownVentilatory Adaptation to Concentric Versus Eccentric Exercise in Patients With Severe COPD (CONvEX)Chronic Obstructive Pulmonary Disease SevereFrance
-
Gachon University Gil Medical CenterCompletedThe Effect of Positive End Expiratory Pressure (PEEP) During Laparoscopic Cholecystectomy (lapaPEEP)Brain IschemiaKorea, Republic of
-
Al-Azhar UniversityCompletedPulmonary Atelectasis, PostoperativeEgypt
-
Zhujiang HospitalCompletedChronic Obstructive Pulmonary DiseaseChina